Matt Teague, a lawyer in our Mass Tort section, was appointed by U.S. District Judge Matthew Kennelly to serve as a member of the Plaintiff’s Steering Committee (PSC) for MDL No. 2545, In re... Read more
In a related matter, the U.S. Food and Drug Administration (FDA) is requiring manufacturers to include a general warning in the drug labeling of all approved testosterone products about the... Read more
On June 6, 2014, the United States Judicial Panel on Multidistrict Litigation (JPML) (the panel) established MDL No. 2545, In re: Testosterone Replacement Therapy Products Liability Litigati... Read more
On November 6, 2013, the Journal of the American Medical Association (JAMA) reported that “a recent randomized clinical trial of testosterone therapy in men with a high prevalence of cardiov... Read more
Matt Teague, a lawyer in our Mass Torts section, joined the firm on March 1, 2011. Since coming on board, Matt has been heavily involved in the firm’s Hormone Replacement Therapy litig... Read more
If you would like to subscribe to the Jere Beasley Report digital edition, simply visit our Subscriptions page and provide the necessary information or call us at 800-898-2034.
Attorney Advertising - Prior results do not guarantee a similar outcome.